TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,955,000 | +17.2% | 2,019,400 | -15.9% | 0.32% | -27.2% |
Q2 2022 | $10,200,000 | +3.7% | 2,400,000 | +132.0% | 0.43% | +45.2% |
Q1 2022 | $9,840,000 | -54.8% | 1,034,663 | -9.7% | 0.30% | -72.2% |
Q4 2021 | $21,774,000 | +13.5% | 1,146,000 | +98.9% | 1.08% | -26.7% |
Q3 2021 | $19,176,000 | +23.6% | 576,200 | +44.0% | 1.47% | +73.2% |
Q2 2021 | $15,516,000 | – | 400,000 | – | 0.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |